ArticleJournal of translational medicine2020

A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model.

Yunlong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.